top of page

Topic

Biomarkers

19 Podcasts • 2 Courses on BackTable

Immune Therapy Innovations for BCG Unresponsive Cancer
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Urology

Episode # 305  •  02 Jun 2026

Immune Therapy Innovations for BCG Unresponsive Cancer

Ready to move beyond “one-size-fits-all” for BCG-unresponsive NMIBC? In this episode of BackTable Urology, Dr. Ruchika Talwar hosts Dr. Sam Chang to discuss the evolving treatment landscape for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). They explore why BCG may fail, the science and clinical rationale behind new immunotherapies and gene therapies, practical approaches to patient selection, treatment sequencing, and surveillance, and the value of emerging biomarkers, empowering urologists to make more informed, personalized decisions in complex cases of NMIBC.

This podcast is supported by

ANKTIVA

More on Biomarkers

Loading recent podcasts…

Urology

Urology Episode #305

Jun 2, 2026

with Dr. Sam Chang, Dr. Ruchika Talwar

Immune Therapy Innovations for BCG Unresponsive Cancer

Ready to move beyond “one-size-fits-all” for BCG-unresponsive NMIBC? In this episode of BackTable Urology, Dr. Ruchika...

Urology

Urology Episode #301

May 5, 2026

with Dr. Udit Singhal, Dr. Ruchika Talwar

Integrating Biomarkers in Prostate Cancer Treatment

Are biomarkers the missing link in personalized prostate cancer care? What is the practical role of biomarkers across...

1,300+ listens

Curbsiders

Curbsiders Episode #511

Jan 12, 2026

with Dr. Halima Amjad, Dr. Natalie Barrett, Dr. Matthew Watto, Dr. Paul Williams

Alzheimer's Disease: Updates in Diagnosis & Treatment

From blood-based biomarkers to anti-amyloid treatments, join us as we explore the latest in Alzheimer's disease...

Urology

Urology Episode #271

Nov 7, 2025

with Dr. Katie Murray, Dr. Sarah Psutka, Dr. Vignesh Packiam

How Biomarkers Enhance Precision Medicine in Non-Muscle Invasive Bladder Cancer

As new genetic and AI-powered tools emerge for bladder cancer screening, are we getting closer to reducing the need for...

1,300+ listens

Tumor Board

Tumor Board Episode #58

May 5, 2026

with Dr. Craig Lockhart, Dr. Lingling Du, Dr. Jonathan Mizrahi

Advanced Hepatocellular Carcinoma: Navigating Second-Line Therapy Options

When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options...

150+ listens

Tumor Board

Tumor Board Episode #54

Apr 7, 2026

with Dr. Tyler Stewart, Dr. Jun Gong

Clinical Advances in Muscle Invasive Bladder Cancer

Don’t miss the “curative window”! This episode takes a closer look at how evolving perioperative strategies and...

200+ listens

Urology

Urology Episode #275

Nov 21, 2025

with Dr. Mark Tyson, Dr. Sarah Psutka, Dr. Vignesh Packiam

NMIBC Tumor Board: Nuances in Management

When standard therapy fails, it does not have to be the end of the road for high-risk bladder cancer patients. Modern...

1,300+ listens

Urology

Urology Episode #269

Oct 28, 2025

with Dr. Jason Hafron, Dr. Ruchika Talwar

Beyond PSA: The Science Driving Smarter Blood Tests

We have relied on PSA for decades, but what’s next in precision screening for prostate cancer? In this episode of...

1,700+ listens

This podcast is for informational purposes only. The views and opinions expressed in this podcast are solely those of the moderator and individual guest.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page